Your compliance team wants clear guidance. The regulations aren't there yet. So what do you do?
For healthcare organizations managing translated member communications, clinical content, and patient-facing materials, the absence of clear AI rules isn't a reason to wait—it's a reason to get ahead. Because when the standards do arrive, they'll reflect what the best-run programs are already doing. “Practice becomes policy” is a pattern the industry has followed before and AI in translation is next.
Join Renato Beninatto, Co-Founder, Nimdzi and David Paré, GM of Life Sciences, Smartling—two of the industry’s most experienced voices—for a candid conversation on what responsible AI translation governance looks like today, what the regulatory signals are telling us, and how to build a program you can defend to any auditor and any administration.
Vad vi kommer att täcka:
-
- Why AI translation practices today will become the compliance standards tomorrow — and what that means for your program
- How to scale managed care translation without scaling headcount
- How to manage PII/PHI, HIPAA compliance
- How to process high-volume content like grievance letters and EOBs
- What FDA, ISO, and the current regulatory landscape are signaling about where rules are headed
- Why AI translation practices today will become the compliance standards tomorrow — and what that means for your program
